Qiming Venture Partners
Mr. William Hu is a Managing Partner of Qiming Venture Partners. William co-leads Qiming's investments in the healthcare sector.
William has been closely involved in the development of over 40 startup firms, some of which have become public companies or billion-dollar market cap companies.
William has led investments in Tigermed(SZSE: 300347, SEHK:3347), BBI Lifescience (HK: 01035), Tellgen(SZ: 300642), AmoyDx(SZ: 300685), APT Medical, Sanyou Medical (SHSE:688085) , Vinno Medical, Aohua Medical, Microtech Medical，Rendu Bio, ET Healthcare, Canbridge, Ark Bio, Connect Pharma, Antengene, WeDoctor, Medsci, Arrail Dental,Bang'Er orthopedics Hospitals, ShuLan Hospital, Centreherbs, etc.
William earned a Bachelor of Medicine degree from Shanghai Medical University and an MBA degree from ENPC SH Campus.
This person is not in any offices
Qiming Venture Partners
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Shenzhen, Hong Kong, Seattle, Boston and the San Francisco Bay Area. Currently Qiming Venture Partners manages nine US Dollar funds and six RMB funds with over $5.6 billion assets under management. Since our establishment, we have invested in outstanding companies in the TMT and healthcare industries at the early and growth stages.